Biotage AB Cash Flow Conversion Efficiency

Latest as of March 2025: 0.011x

Biotage AB cash flow conversion efficiency. Based on the latest financial reports, Biotage AB (BIOT) has a cash flow conversion efficiency ratio of 0.011x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr43.00 Million ≈ $4.63 Million USD) by net assets (Skr3.85 Billion ≈ $413.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Biotage AB (2002–2024)

Cash flow conversion efficiency of Biotage AB from 2002 to 2024. This chart illustrates how Biotage AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Biotage AB stock price for real-time trading data and today's change.

Biotage AB Cash Flow Conversion Ratio Explained

Biotage AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Biotage AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biotage AB ranked by their cash flow conversion efficiency. Also see how much is Biotage AB worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Treehouse Foods Inc NYSE:THS	0.030x
Global Brands Manufacture Ltd TW:6191	0.059x
Goodyear Tire & Rubber Co NASDAQ:GT	0.033x
Jade Bird Fire Alarm SHE:002960	-0.011x
Zhengzhou GL Tech Co Ltd SHE:300480	-0.004x
Jinlongyu Group Co Ltd Class A SHE:002882	-0.248x
Tourmaline Bio Inc. NASDAQ:TRML	-0.078x
Vitec Software Group AB (publ) ST:VIT-B	0.018x

Annual Cash Flow Conversion Efficiency for Biotage AB (2002–2024)

The table below shows the annual cash flow conversion efficiency of Biotage AB from 2002 to 2024. Review cash generation quality of Biotage AB to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr4.11 Billion ≈ $442.62 Million	Skr413.00 Million ≈ $44.45 Million	0.100x	+29.30%
2023-12-31	Skr3.66 Billion ≈ $393.55 Million	Skr284.00 Million ≈ $30.56 Million	0.078x	-62.72%
2022-12-31	Skr1.64 Billion ≈ $176.17 Million	Skr341.00 Million ≈ $36.70 Million	0.208x	-19.04%
2021-12-31	Skr1.37 Billion ≈ $147.65 Million	Skr353.00 Million ≈ $37.99 Million	0.257x	-8.72%
2020-12-31	Skr990.04 Million ≈ $106.54 Million	Skr279.05 Million ≈ $30.03 Million	0.282x	+16.50%
2019-12-31	Skr875.50 Million ≈ $94.22 Million	Skr211.81 Million ≈ $22.79 Million	0.242x	+9.59%
2018-12-31	Skr702.18 Million ≈ $75.57 Million	Skr155.00 Million ≈ $16.68 Million	0.221x	-20.47%
2017-12-31	Skr608.61 Million ≈ $65.50 Million	Skr168.93 Million ≈ $18.18 Million	0.278x	+12.42%
2016-12-31	Skr563.24 Million ≈ $60.61 Million	Skr139.07 Million ≈ $14.97 Million	0.247x	+12.41%
2015-12-31	Skr546.66 Million ≈ $58.83 Million	Skr120.08 Million ≈ $12.92 Million	0.220x	+36.47%
2014-12-31	Skr502.65 Million ≈ $54.09 Million	Skr80.91 Million ≈ $8.71 Million	0.161x	+35.21%
2013-12-31	Skr476.77 Million ≈ $51.31 Million	Skr56.76 Million ≈ $6.11 Million	0.119x	-15.15%
2012-12-31	Skr530.83 Million ≈ $57.13 Million	Skr74.47 Million ≈ $8.01 Million	0.140x	-27.45%
2011-12-31	Skr563.90 Million ≈ $60.68 Million	Skr109.05 Million ≈ $11.74 Million	0.193x	+90.70%
2010-12-31	Skr567.95 Million ≈ $61.12 Million	Skr57.59 Million ≈ $6.20 Million	0.101x	+204.67%
2009-12-31	Skr1.09 Billion ≈ $117.20 Million	Skr36.25 Million ≈ $3.90 Million	0.033x	-57.81%
2008-12-31	Skr1.12 Billion ≈ $121.05 Million	Skr88.74 Million ≈ $9.55 Million	0.079x	+86.31%
2007-12-31	Skr796.26 Million ≈ $85.69 Million	Skr33.72 Million ≈ $3.63 Million	0.042x	-24.40%
2006-12-31	Skr712.47 Million ≈ $76.67 Million	Skr39.91 Million ≈ $4.29 Million	0.056x	+303.79%
2005-12-31	Skr738.25 Million ≈ $79.45 Million	Skr-20.29 Million ≈ $-2.18 Million	-0.027x	+85.31%
2004-12-31	Skr523.13 Million ≈ $56.30 Million	Skr-97.89 Million ≈ $-10.53 Million	-0.187x	-13.75%
2003-12-31	Skr609.50 Million ≈ $65.59 Million	Skr-100.27 Million ≈ $-10.79 Million	-0.165x	+20.20%
2002-12-31	Skr616.16 Million ≈ $66.31 Million	Skr-127.02 Million ≈ $-13.67 Million	-0.206x	--

About Biotage AB

ST:BIOT Sweden Medical Instruments & Supplies

Market Cap

$1.23 Billion

Skr11.46 Billion SEK

Market Cap Rank

#7721 Global

#127 in Sweden

Share Price

Skr143.20

Change (1 day)

+0.00%

52-Week Range

Skr143.20 - Skr143.20

All Time High

Skr280.87